Zacks.com on MSN2d
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag EstimatesCollegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback